| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
|
Ferro, Matteo
|
|
|
22 |
2 |
p. 27-37
|
artikel
|
| 2 |
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer
|
Boiarsky, Daniel
|
|
|
22 |
2 |
p. 558-568.e3
|
artikel
|
| 3 |
Assessing the Impact of Percutaneous Nephrostomy Presence on Neoadjuvant Treatment Quality in Patients With Muscle Invasive Bladder Cancer
|
Savin, Ziv
|
|
|
22 |
2 |
p. 491-496
|
artikel
|
| 4 |
Association Between Kidney Function and Outcomes Following Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Carcinoma
|
Ishihara, Hiroki
|
|
|
22 |
2 |
p. 549-557.e5
|
artikel
|
| 5 |
Bladder Cancer and the Urinary Microbiome—New Insights and Future Directions: A Review
|
Russo, Angela E.
|
|
|
22 |
2 |
p. 434-444
|
artikel
|
| 6 |
Bladder-Preserving Trimodality Therapy With Capecitabine
|
Lynch, Connor
|
|
|
22 |
2 |
p. 476-482.e1
|
artikel
|
| 7 |
Carboplatin in Metastatic Castrate Resistant Prostate Cancer: A Retrospective Study of Heavily Pretreated Patients (COMPACT)
|
Pemberton, Lara
|
|
|
22 |
2 |
p. 580-585
|
artikel
|
| 8 |
CD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma
|
Huang, Rong Rong
|
|
|
22 |
2 |
p. 347-353
|
artikel
|
| 9 |
Central Nervous System Disease Progression Among Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Case Series
|
Shipp, Chase
|
|
|
22 |
2 |
p. 315-321
|
artikel
|
| 10 |
Chronic Glucocorticoid Use and Risk for Advanced Prostate Cancer at Presentation: A SEER-Medicare Cohort Study
|
Singh, Zorawar
|
|
|
22 |
2 |
p. 68-73.e2
|
artikel
|
| 11 |
Circulating Basophils as a Prognostic Marker for Response to Bacillus Calmette-Guérin
|
Trépanier, Geneviève
|
|
|
22 |
2 |
p. 354-359.e1
|
artikel
|
| 12 |
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-Analysis
|
Miyajima, Keiichiro
|
|
|
22 |
2 |
p. 149-156.e1
|
artikel
|
| 13 |
Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy
|
van der Zande, K.
|
|
|
22 |
2 |
p. 445-453.e1
|
artikel
|
| 14 |
Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices to Improve the Prediction of Perioperative Morbidity and Long-Term Survival Outcomes After Radical Cystectomy
|
von Deimling, Markus
|
|
|
22 |
2 |
p. 336-346.e9
|
artikel
|
| 15 |
Corrigendum
|
|
|
|
22 |
2 |
p. 367
|
artikel
|
| 16 |
Cystic Pelvic Masses in Men: A Presentation of Uncommon Cases and a Literature Review
|
Rieger, Constantin
|
|
|
22 |
2 |
p. 523-534
|
artikel
|
| 17 |
Diagnostic and Prognostic Value of Neutrophil-Lymphocyte Ratio in Adrenocortical Carcinoma
|
Ma, Chengquan
|
|
|
22 |
2 |
p. 109-114
|
artikel
|
| 18 |
Does Bladder Cancer Subtype Influence Pathologic Complete Response (pCR) and Pelvic Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) Response Evaluation After Neoadjuvant Chemotherapy? Pathological Perspective
|
Kim, Ji Min
|
|
|
22 |
2 |
p. 224-236
|
artikel
|
| 19 |
Effect of Socioeconomic Disparities on Suicide Risk in Patients With Prostate Cancer During 2005 to 2020: A Population Study
|
Jia, Yi-Jie
|
|
|
22 |
2 |
p. 84-91.e7
|
artikel
|
| 20 |
First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies
|
Fenor de la Maza, María Dolores
|
|
|
22 |
2 |
p. 330-335
|
artikel
|
| 21 |
Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or Enzalutamide
|
Riekhof, Forest
|
|
|
22 |
2 |
p. 18-26.e3
|
artikel
|
| 22 |
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib
|
Catalano, Martina
|
|
|
22 |
2 |
p. 514-522.e1
|
artikel
|
| 23 |
Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
|
Campbell, Rebecca A.
|
|
|
22 |
2 |
p. 157-163.e1
|
artikel
|
| 24 |
Incidental Coronary Arterial Calcification for Cardiovascular Risk Assessment in Men With Prostate Cancer Undergoing PET/CT Imaging
|
Shaikh, Preet A.
|
|
|
22 |
2 |
p. 586-592
|
artikel
|
| 25 |
Integration of Multiparameter MRI into Conventional Pretreatment Risk Factors to Predict Positive Surgical Margins After Radical Prostatectomy
|
Ma, Ming-Wei
|
|
|
22 |
2 |
p. 281-290.e1
|
artikel
|
| 26 |
Intermittent Versus Continuous Androgen Deprivation Therapy for Biochemical Progression After Primary Therapy in Hormone-Sensitive Nonmetastatic Prostate Cancer: Comparative Analysis in Terms of CRPC-M0 Progression
|
Salciccia, Stefano
|
|
|
22 |
2 |
p. 74-83
|
artikel
|
| 27 |
Leveraging a Genomic Instability-Derived Signature to Predict the Prognosis and Therapy Sensitivity of Clear Cell Renal Cell Carcinoma
|
Wei, Chuzhong
|
|
|
22 |
2 |
p. 134-148.e8
|
artikel
|
| 28 |
Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal
|
Staehler, Michael
|
|
|
22 |
2 |
p. 189-192
|
artikel
|
| 29 |
Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell Carcinoma
|
Grünwald, Viktor
|
|
|
22 |
2 |
p. 394-401
|
artikel
|
| 30 |
Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion
|
Soares, Andrey
|
|
|
22 |
2 |
p. 467-475
|
artikel
|
| 31 |
Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all Stages
|
Siech, Carolin
|
|
|
22 |
2 |
p. 593-598
|
artikel
|
| 32 |
Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection
|
Tiruye, Tenaw
|
|
|
22 |
2 |
p. 599-609.e2
|
artikel
|
| 33 |
National Trends in Management of Newly Diagnosed Prostate Cancer
|
Maganty, Avinash
|
|
|
22 |
2 |
p. 10-17
|
artikel
|
| 34 |
Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients
|
Fujiwara, Motohiro
|
|
|
22 |
2 |
p. 193-200.e1
|
artikel
|
| 35 |
Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer
|
Emperumal, Chitra Priya
|
|
|
22 |
2 |
p. 380-384
|
artikel
|
| 36 |
Other-Cause Mortality, According to Partial vs. Radical Nephrectomy: Age and Stage Analyses
|
Baudo, Andrea
|
|
|
22 |
2 |
p. 181-188
|
artikel
|
| 37 |
Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paraganglioma
|
Park, Young-Gyu
|
|
|
22 |
2 |
p. 413-419
|
artikel
|
| 38 |
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites
|
Tappero, Stefano
|
|
|
22 |
2 |
p. 47-55.e2
|
artikel
|
| 39 |
PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing Evidence
|
Ditonno, Francesco
|
|
|
22 |
2 |
p. 402-412.e17
|
artikel
|
| 40 |
Patients With Muscle-Invasive Bladder Cancer With Lymphovascular Invasion in Transurethral Resection Specimen Benefits Most From Platinum-Based Neoadjuvant Chemotherapy
|
Wang, Ziwei
|
|
|
22 |
2 |
p. 201-209.e7
|
artikel
|
| 41 |
Perioperative and Survival Outcomes of Patients Treated With Robot-Assisted Partial Nephrectomy and Percutaneous Microwave Ablation for Small Renal Masses: A Single Center Experience
|
Lucignani, Gianpaolo
|
|
|
22 |
2 |
p. 237-243
|
artikel
|
| 42 |
Predictors of Response Following Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Urothelial Bladder Cancer Using Molecular Profile: A Prospective Clinical Study
|
Elkarta, Ahmed
|
|
|
22 |
2 |
p. 38-46.e1
|
artikel
|
| 43 |
Preoperative Immunonutrition Significantly Reduced Surgical Site Infection After Urinary Diversion for Invasive Bladder Cancer: A Retrospective Cohort Study
|
Takeuchi, Hiroki
|
|
|
22 |
2 |
p. 360-366
|
artikel
|
| 44 |
Prognosis and Clinicopathological Characters of Adult TFEB-Altered Renal Cell Carcinoma: A Single Center Experience of 18 Cases
|
Wu, Jie
|
|
|
22 |
2 |
p. 261-268.e3
|
artikel
|
| 45 |
Prognostic Impact of the Modified 5-Item Frailty Index After Radical Nephroureterectomy in Patients With Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study
|
Kohada, Yuki
|
|
|
22 |
2 |
p. 322-329.e3
|
artikel
|
| 46 |
Prognostic Significance of Lymph Node Density in Pathological Node Positive Urothelial Carcinoma of the Bladder -Upfront Surgery and Post Neoadjuvant Chemotherapy Cohorts
|
Jaganmurugan, Ramamurthy
|
|
|
22 |
2 |
p. 385-393
|
artikel
|
| 47 |
Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients
|
Scheipner, Lukas
|
|
|
22 |
2 |
p. 164-170
|
artikel
|
| 48 |
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9)
|
Damassi, Alessandra
|
|
|
22 |
2 |
p. 126-133.e2
|
artikel
|
| 49 |
Prostate Cancer and Malignant Ascites: The Mayo Clinic Experience With a Rare and Aggressive Disease Progression
|
Mahmoud, Ahmed M.
|
|
|
22 |
2 |
p. 291-294
|
artikel
|
| 50 |
Prostate Specific Antigen Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision Making
|
Dalela, Deepansh
|
|
|
22 |
2 |
p. 269-280.e2
|
artikel
|
| 51 |
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study
|
Kafka, Mona
|
|
|
22 |
2 |
p. 458-466.e1
|
artikel
|
| 52 |
Real-World Results of Cabozantinib Given as Alternative Schedule in Metastatic Renal Cell Carcinoma
|
Bruchbacher, Andreas
|
|
|
22 |
2 |
p. 98-108
|
artikel
|
| 53 |
Real-World Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma
|
Esterberg, Elizabeth
|
|
|
22 |
2 |
p. 115-125.e3
|
artikel
|
| 54 |
Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study
|
Albigès, Laurence
|
|
|
22 |
2 |
p. 295-304.e6
|
artikel
|
| 55 |
Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell Carcinoma
|
Schuster, James
|
|
|
22 |
2 |
p. 92-97
|
artikel
|
| 56 |
Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study
|
Huang, Tingxuan
|
|
|
22 |
2 |
p. 252-260.e3
|
artikel
|
| 57 |
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events
|
Nizam, Amanda
|
|
|
22 |
2 |
p. 368-379
|
artikel
|
| 58 |
Sex Does Not Affect Survival: A Propensity Score-Matched Comparison in a Homogenous Contemporary Radical Cystectomy Cohort
|
Stangl, Fabian P.
|
|
|
22 |
2 |
p. 171-180
|
artikel
|
| 59 |
SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma
|
Jiang, Aimin
|
|
|
22 |
2 |
p. 497-513
|
artikel
|
| 60 |
Surveillance or Dynamic Sentinel Lymph-Node Biopsy in Low-Risk Clinically N0 Penile Squamous Cell Carcinoma: Single-Institution Real World Data
|
Nazzani, Sebastiano
|
|
|
22 |
2 |
p. 544-548
|
artikel
|
| 61 |
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study
|
Monteiro, Fernando Sabino Marques
|
|
|
22 |
2 |
p. 305-314.e3
|
artikel
|
| 62 |
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis
|
Pisano, Chiara
|
|
|
22 |
2 |
p. 56-67.e16
|
artikel
|
| 63 |
Testicular Seminoma in Prostate: Case Report and Review of Literature
|
Lesko, Peter
|
|
|
22 |
2 |
p. 210-216
|
artikel
|
| 64 |
The Ability of the STAR-CAP Staging System to Prognosticate the Risk of Subsequent Therapies and Metastases After Initial Treatment of M0 Prostate Cancer
|
Sung, Daeun
|
|
|
22 |
2 |
p. 426-433.e5
|
artikel
|
| 65 |
The Effect of Treatment Intensification on Other-Cause Mortality in Clear-Cell Metastatic Renal Cell Carcinoma Patients
|
Incesu, Reha-Baris
|
|
|
22 |
2 |
p. 420-425
|
artikel
|
| 66 |
The Efficacy of Ketoconazole Containing Regimens in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
|
Rehman, Obaid Ur
|
|
|
22 |
2 |
p. 483-490.e5
|
artikel
|
| 67 |
The Impact of a Multidisciplinary Tumor Board (MTB) on Treatment Decision Making for Patients With Renal Cell Carcinoma (RCC): 5-Year Data Analysis
|
Brink, Luna van den
|
|
|
22 |
2 |
p. 610-617.e1
|
artikel
|
| 68 |
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study
|
Marra, Giancarlo
|
|
|
22 |
2 |
p. 244-251
|
artikel
|
| 69 |
The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis
|
Kawada, Tatsushi
|
|
|
22 |
2 |
p. 535-543.e4
|
artikel
|
| 70 |
Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
|
Mar, Nataliya
|
|
|
22 |
2 |
p. 217-223
|
artikel
|
| 71 |
The Role of Lymph Node Dissection in Patients With Muscle-Invasive Bladder Cancer Who Underwent Radical Cystectomy Following Neoadjuvant Chemotherapy
|
Zennami, Kenji
|
|
|
22 |
2 |
p. 1-9
|
artikel
|
| 72 |
Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment
|
Yuan, Hejia
|
|
|
22 |
2 |
p. 569-579.e1
|
artikel
|
| 73 |
Urological Cancers and ChatGPT: Assessing the Quality of Information and Possible Risks for Patients
|
Ozgor, Faruk
|
|
|
22 |
2 |
p. 454-457.e4
|
artikel
|
Tijdschrift beschrijving